ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Gut bacterial profiles in Parkinson's disease: A systematic review

Li, Zhe; Liang, Hongfeng; Hu, Yingyu; Lu, Lin; Zheng, Chunye; Fan, Yuzhen; Wu, Bin; Zou, Tao; Luo, Xiaodong; Zhang, Xinchun; Zeng, Yan; Liu, Ziyan; Zhou, Zhicheng; Yue, Zhenyu; Ren, Yi; Li, Zhuo; Su, Qiaozhen*; Xu, Pingyi*广东省人民医院; 广州医学院; 广州中医药大学; 南方医科大学; 1
CNS Neuroscience & Therapeutics2023-1DOI: 10.1111/cns.13990
22被引4阅读
引用收藏
分享

摘要

Introduction Recent advances have highlighted the relationships between gut dysbiosis and Parkinson's disease (PD). Microbiota transplantation from PD patients to mice can induce increased alpha-synuclein-mediated motor deficits. Human studies have identified differences in the gut microbiota of PD patients compared to healthy controls. We undertook a systematic review to evaluate the available evidence for the involvement of gut bacteria in the etiology of PD. Methods The PubMed databank, the China National Knowledge Infrastructure databank, and Wanfang Data were searched from inception until June 2021 to identify human case-control studies that investigated relationships between PD and microbiota quantified from feces. We evaluated the resulting studies focusing on bacterial taxa that were different between PD patients and healthy controls. Results Twenty-six studies were found in which 53 microbial families and 98 genera exhibited differences between patients with PD and healthy controls. The genera identified by more than two studies as increased in PD were Bifidobacterium, Alistipes, Christensenella, Enterococcus, Oscillospira, Bilophila, Desulfovibrio, Escherichia/Shigella, and Akkermansia, while Prevotella, Blautia, Faecalibacterium, Fusicatenibacter, and Haemophilus had three or more reports of being lower in PD patients. More than one report demonstrated that Bacteroides, Odoribacter, Parabacteroides, Butyricicoccus, Butyrivibrio, Clostridium, Coprococcus, Lachnospira, Lactobacillus, Megasphaera, Phascolarctobacterium, Roseburia, Ruminococcus, Streptococcus, and Klebsiella were altered in both directions. Conclusion Our review shows that the involvement of the gut microbiome in the etiology of PD may involve alterations of short-chain fatty acids (SCFAs)-producing bacteria and an increase in putative gut pathobionts. SCFAs-producing bacteria may vary above or below an "optimal range," causing imbalances. Considering that Bifidobacterium, Lactobacillus, and Akkermansia are beneficial for human health, increased Bifidobacterium and Lactobacillus in the PD gut microbiome may be associated with PD medications, especially COMT inhibitors, while a high level of Akkermansia may be associated with aging.

学科与关键词

关键词
Parkinson's diseasegut bacteriafamilygenussystematic review
相关
加载中…
  • The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options
    Wang, Qing*; Luo, Yuqi; Chaudhuri, K. Ray; Reynolds, Richard; Tan, Eng-King*; Pettersson, Sven*Brain; a journal of neurology, 2021, 144: 2571-2593.被引 98
  • Oral, Nasal, and Gut Microbiota in Parkinson's Disease
    Li, Zhuo; Lu, Gang; Luo, Enli; Wu, Bin; Li, Zhe; Guo, Jianwen; Xia, Zhangyong; Zheng, Chunye; Su, Qiaozhen; Zeng, Yan; Chan, Wai Yee; Su, Xianwei; Qiu, Xinmin; Zheng, Xirun; Cai, Qiaodi; Xu, Yanjuan; Chen, Yingjun; Fan, Yuzhen; Chen, Weiwei; Yu, Zecheng; Chen, Xinjie; Zheng, Chunying; Wang, Mingbang; Poon, Wai Sang*; Luo, Xiaodong*Neuroscience, 2022, 480: 65-78.被引 21
  • Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson?s disease: An animal study
    Yan, Zhenzhen; Yang, Fan; Sun, Linlin; Yu, Jing; Sun, Lina; Si, Yao; Yao, Lifen*Brain, Behavior, and Immunity, 2022, 106: 307-321.被引 18
查看全部 →

发表信息

论文状态
公开发表
期刊
CNS Neuroscience & Therapeutics
发表日期
2023-01
卷期
第 29 卷, 第 1 期
页码
140-157
DOI
10.1111/cns.13990
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Projects of China [2016YFC1306601, 2017YFC1310300]; National Natural Science Foundation of China [81373712, 81873358, 81870992, 82004459]; Nature Science Foundation of Guangdong Province [2018A030310521]; Research Project of Traditional Chinese Medicine Bureau of Guangdong Province [20221160]; Science and Technology Planning Project of Guangzhou [201604020152, 201803040020]; Research Fund for Zhaoyang Talents of Guangdong Provincial Hospital of Chinese Medicine [ZY2022KY09]

作者

  • L

    Li, Zhe (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liang, Hongfeng

    2 · guangdong prov hosp · guangzhou univ chinese med

查看全部 18 位作者收起作者
  • H

    Hu, Yingyu

    southern med univ

  • L

    Lu, Lin

    1 · guangzhou med univ

  • Z

    Zheng, Chunye

    2 · guangdong prov hosp · guangzhou univ chinese med

  • F

    Fan, Yuzhen

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Bin

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zou, Tao

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Luo, Xiaodong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhang, Xinchun

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zeng, Yan

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Ziyan

    2 · guangzhou univ chinese med

  • Z

    Zhou, Zhicheng

    2 · guangzhou univ chinese med

  • Y

    Yue, Zhenyu

    new

  • R

    Ren, Yi

  • L

    Li, Zhuo

    2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Su, Qiaozhen (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xu, Pingyi (通讯)

    1 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417